Ariel Weinberger | Chief Executive Officer
Autonomous

Ariel Weinberger, Chief Executive Officer, Autonomous

Appearances:

WVIC/WAC Day 1 - Nov 29 @ 11:45

How can we utilize mRNA technology to develop next generation therapeutics?

Ariel Weinberger, Chief Executive Officer, Autonomous Therapeutics

WVIC/WAC Day 3 - Dec 1 @ 11:10

Showcase 2: A new class of RNA for pan-variant immunity

Ariel Weinberger, Chief Executive Officer, Autonomous Therapeutics

WVIC/WAC Day 3 - Dec 1 @ 11:10

Variant proof RNA Therapeutics

Ariel Weinberger, Chief Executive Officer, Autonomous Therapeutics

last published: 01/Dec/22 17:25 GMT

back to speakers

For conference programme and speaking opportunities:
Lauren Sheppard
lauren.sheppard@terrapinn.com

For sponsorship and exhibition opportunities:
Thomas Hall
thomas.hall@terrapinn.com